Incyte
INCY
#980
Rank
HK$191.23 B
Marketcap
HK$938.22
Share price
1.39%
Change (1 day)
13.84%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2023 (TTM): HK$14.88

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$16.47. In 2022 the company made an earnings per share (EPS) of HK$12.08 a decrease over its 2021 EPS that were of HK$33.64.

EPS history for Incyte from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$14.8823.25%
2022HK$12.08-64.1%
2021HK$33.64-408.63%
2020-HK$10.90-166.83%
2019HK$16.31300%
2018HK$4.08-133.33%
2017-HK$12.23-378.57%
2016HK$4.392700%
2015HK$0.16-106.67%
2014-HK$2.35-44.44%
2013-HK$4.2350%
2012-HK$2.82-75.68%
2011-HK$11.61469.23%
2010-HK$2.04-87.38%
2009-HK$16.154.04%
2008-HK$15.5392.23%
2007-HK$8.0815.73%
2006-HK$6.98-27.64%
2005-HK$9.64-44.34%
2004-HK$17.33-5.56%
2003-HK$18.3515.27%
2002-HK$15.92-26.71%
2001-HK$21.72483.16%
2000-HK$3.72-1.04%
1999-HK$3.76-838.46%
1998HK$0.51-59.38%
1997HK$1.25-194.12%
1996-HK$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.03 1,369.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.19 672.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.49 376.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.86-105.24%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.55-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.59-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.73-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA